Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
暂无分享,去创建一个
T. Kroll | I. Runnebaum | K. Pachmann | O. Camara | A. Kavallaris | S. Krauspe | Nele Malarski | M. Gajda | C. Jörke | U. Hammer | A. Altendorf-Hofmann | C. Rabenstein | U. Pachmann | K. Höffken
[1] N. Ditsch,et al. [Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value]. , 2002, MMW Fortschritte der Medizin.
[2] M. Campone,et al. Taxanes in adjuvant breast cancer setting: which standard in Europe? , 2005, Critical reviews in oncology/hematology.
[3] U. Schneider,et al. Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring , 2005, Breast Cancer Research.
[4] T. Kroll,et al. An increase in cell number at completion of therapy may develop as an indicator of early relapse , 2007, Journal of Cancer Research and Clinical Oncology.
[5] D. Hayes,et al. The measurement and therapeutic implications of circulating tumour cells in breast cancer , 2005, British Journal of Cancer.
[6] R K Jain,et al. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. , 1999, Cancer research.
[7] Dominik Wodarz,et al. Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Gullino,et al. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.
[9] Jason L. Townson,et al. Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases , 2003, Breast Cancer Research and Treatment.
[10] N. Harbeck,et al. Detection of micrometastatic disease in bone marrow: is it ready for prime time? , 2005, The oncologist.
[11] R. Coombes,et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study , 1999, The Lancet.
[12] K. Pachmann. Longtime Recirculating Tumor Cells in Breast Cancer Patients , 2005, Clinical Cancer Research.
[13] S. Braun,et al. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence , 2005, Cancer.
[14] R. Demicheli,et al. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour , 2004, Breast Cancer Research.
[15] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[16] G. Tilz,et al. Detection and Quantification of Small Numbers of Circulating Tumour Cells in Peripheral Blood Using Laser Scanning Cytometer (LSC®) , 2001, Clinical chemistry and laboratory medicine.
[17] K. Pachmann,et al. Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells , 2006, World journal of surgical oncology.
[18] C. Rao,et al. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] T. Fehm,et al. A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.
[20] Thomas Rau,et al. Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity , 2005, Clinical Cancer Research.
[21] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[22] K. Pachmann,et al. Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: an increase in cell number at completion of therapy is a predictor of early relapse. , 2007, Breast.
[23] C. Sawyers. Calculated resistance in cancer , 2005, Nature Medicine.
[24] G. Bastert,et al. Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] T. Fehm,et al. Influence of tumor biological factors on tumor cell dissemination in primary breast cancer. , 2004, Anticancer research.
[26] D. Ghersi,et al. Single agent versus combination chemotherapy for metastatic breast cancer. , 2009, The Cochrane database of systematic reviews.
[27] Tanja Fehm,et al. Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.
[28] Christopher W. Wong,et al. Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.
[29] W. Holzgreve,et al. Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples , 2006, Breast Cancer Research.
[30] Katharina Pachmann,et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer , 2005, Clinical chemistry and laboratory medicine.
[31] M. Untch,et al. The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] A. Jones,et al. Reduction in mortality from breast cancer , 2005, BMJ : British Medical Journal.
[33] G. Bonadonna,et al. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study , 2005, BMJ : British Medical Journal.